logo
Verve Therapeutics Leads The Charge With 2 Other Promising Penny Stocks

Verve Therapeutics Leads The Charge With 2 Other Promising Penny Stocks

Yahoo4 days ago

As the U.S. market navigates a mixed landscape with rising Treasury yields and a recent credit rating downgrade, investors are increasingly looking for opportunities that balance risk and reward. Penny stocks, often overlooked, continue to offer potential growth avenues particularly when they are underpinned by strong financials. These smaller or newer companies can present unique opportunities for those willing to explore beyond the mainstream indices, and we'll highlight three promising examples in this space that may offer hidden value.
Name
Share Price
Market Cap
Financial Health Rating
Safe Bulkers (NYSE:SB)
$3.75
$393.17M
★★★★☆☆
Tuya (NYSE:TUYA)
$2.73
$1.64B
★★★★★★
Perfect (NYSE:PERF)
$1.78
$181.29M
★★★★★★
Flexible Solutions International (NYSEAM:FSI)
$4.40
$55.65M
★★★★★★
Imperial Petroleum (NasdaqCM:IMPP)
$2.51
$86.38M
★★★★★★
Table Trac (OTCPK:TBTC)
$4.7025
$21.82M
★★★★★★
BAB (OTCPK:BABB)
$0.7913
$5.75M
★★★★★★
Lifetime Brands (NasdaqGS:LCUT)
$3.28
$73.52M
★★★★★☆
New Horizon Aircraft (NasdaqCM:HOVR)
$0.6822
$21.41M
★★★★★★
CBAK Energy Technology (NasdaqCM:CBAT)
$0.872
$78.43M
★★★★★☆
Click here to see the full list of 724 stocks from our US Penny Stocks screener.
We'll examine a selection from our screener results.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Verve Therapeutics, Inc. is a clinical-stage company focused on developing gene editing medicines to treat cardiovascular disease in the United States, with a market cap of $412.73 million.
Operations: The company's revenue segment consists solely of $59.61 million from research and development activities related to gene editing medicines.
Market Cap: $412.73M
Verve Therapeutics, Inc., a clinical-stage company with a market cap of US$412.73 million, is currently pre-revenue and unprofitable, though it has made significant strides in its gene editing initiatives for cardiovascular diseases. The recent clearance by the FDA for its investigational new drug VERVE-102 marks a promising step forward in its Heart-2 Phase 1b clinical trial aimed at lowering LDL-C levels. Despite the lack of revenue, Verve's financial health appears stable with short-term assets exceeding liabilities and no debt burden. The company anticipates sufficient capital to sustain operations into mid-2027 while continuing to advance clinical trials.
Click here to discover the nuances of Verve Therapeutics with our detailed analytical financial health report.
Explore Verve Therapeutics' analyst forecasts in our growth report.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Nextdoor Holdings, Inc. operates a neighborhood network connecting neighbors, businesses, and public agencies both in the United States and internationally, with a market cap of approximately $554.75 million.
Operations: The company generated $248.31 million in revenue from its Internet Information Providers segment.
Market Cap: $554.75M
Nextdoor Holdings, Inc. has shown resilience with its recent Q1 2025 earnings, reporting US$54.18 million in sales despite a net loss of US$21.95 million, an improvement from the previous year's loss. The company is debt-free and maintains a solid cash runway for over three years based on current free cash flow. While unprofitable with a negative return on equity of -21.04%, it trades at 57.3% below fair value estimates, potentially offering value to investors seeking growth in the interactive media sector. A recent partnership with Class Intercom enhances its platform's reach among schools and local communities, leveraging its network's extensive user base effectively.
Get an in-depth perspective on Nextdoor Holdings' performance by reading our balance sheet health report here.
Gain insights into Nextdoor Holdings' future direction by reviewing our growth report.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: loanDepot, Inc. operates in the United States by originating, financing, selling, and servicing residential mortgage loans and has a market cap of approximately $405.79 million.
Operations: The company generates revenue of $1.09 billion from originating, financing, and selling mortgage loans.
Market Cap: $405.79M
loanDepot, Inc. operates with a market cap of approximately US$405.79 million and reported revenues of US$1.09 billion from its mortgage operations, yet remains unprofitable with a recent Q1 2025 net loss of US$21.9 million. The company has experienced executive changes, including the transition of Frank Martell and the reappointment of founder Anthony Hsieh as Executive Chairman. loanDepot's management and board are seasoned, with an average tenure exceeding industry norms, while its short-term assets surpass both short- and long-term liabilities. However, high debt levels persist with a net debt to equity ratio considered elevated at 1073%.
Click to explore a detailed breakdown of our findings in loanDepot's financial health report.
Understand loanDepot's earnings outlook by examining our growth report.
Dive into all 724 of the US Penny Stocks we have identified here.
Ready To Venture Into Other Investment Styles? Outshine the giants: these 28 early-stage AI stocks could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:VERV NYSE:KIND and NYSE:LDI.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Roper Technologies, Inc. (ROP): A Bull Case Theory
Roper Technologies, Inc. (ROP): A Bull Case Theory

Yahoo

time24 minutes ago

  • Yahoo

Roper Technologies, Inc. (ROP): A Bull Case Theory

We came across a bullish thesis on Roper Technologies, Inc. (ROP) on FluentinQuality's Substack. In this article, we will summarize the bulls' thesis on ROP. Roper Technologies, Inc. (ROP)'s share was trading at $572.18 as of 10th June. ROP's trailing and forward P/E were 41.32 and 28.82 respectively according to Yahoo Finance. An experienced software engineer working on a complex line of code in a programming suite. Roper Technologies may still carry an industrial-sounding name, but the company has long since transformed into a stealth giant in mission-critical software. Its portfolio spans healthcare, education, insurance, and compliance sectors where reliability and low switching costs reign supreme. Rather than chase trends, Roper quietly acquires foundational software businesses that customers can't operate without, often holding them indefinitely. These aren't flashy, hyper-growth startups but high-retention, capital-light cash generators that offer strong free cash flow from day one. With a disciplined M&A strategy, Roper targets niche market leaders, pays based on cash yield instead of frothy market comps, and preserves each acquisition's operational autonomy. It avoids fixer-uppers and instead builds a collection of enduring franchises. The result is a business model that delivers SaaS-like gross margins north of 60% and operating margins exceeding 30%, all without the volatility or high burn of traditional software players. Its revenue base is highly recurring, providing resilience across market cycles, while reinvestment remains methodical and dividends grow in lockstep with free cash flow. Roper's strength lies in its ability to unify a seemingly diverse portfolio through pricing power, long-term contracts, and dominant positions in fragmented markets. Though under-the-radar and rarely in the headlines, Roper steadily compounds capital with Berkshire-like patience and software economics. For investors seeking reliable, high-margin, cash-generative software with structural staying power, Roper offers a compelling alternative to more speculative tech names. It's not about scale for scale's sake—it's about quiet durability, and Roper has been delivering that in spades for decades. Previously, we highlighted a on Roper Technologies (ROP) by D Invests, which emphasized its transformation from industrial supplier to asset-light software compounder, driven by disciplined M&A and exceptional cash efficiency. FluentInQuality reinforces this view but goes further—casting Roper as a Berkshire-like capital allocator in disguise, quietly assembling high-retention software franchises that deliver SaaS economics without the hype. Roper Technologies, Inc. (ROP) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 46 hedge fund portfolios held ROP at the end of the first quarter which was 54 in the previous quarter. While we acknowledge the risk and potential of ROP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.

InMode Ltd. (NASDAQ:INMD) is largely controlled by institutional shareholders who own 72% of the company
InMode Ltd. (NASDAQ:INMD) is largely controlled by institutional shareholders who own 72% of the company

Yahoo

time24 minutes ago

  • Yahoo

InMode Ltd. (NASDAQ:INMD) is largely controlled by institutional shareholders who own 72% of the company

Institutions' substantial holdings in InMode implies that they have significant influence over the company's share price The top 14 shareholders own 50% of the company 15% of InMode is held by insiders AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. A look at the shareholders of InMode Ltd. (NASDAQ:INMD) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 72% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company. Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute. In the chart below, we zoom in on the different ownership groups of InMode. Check out our latest analysis for InMode Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. We can see that InMode does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see InMode's historic earnings and revenue below, but keep in mind there's always more to the story. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. InMode is not owned by hedge funds. BlackRock, Inc. is currently the company's largest shareholder with 8.9% of shares outstanding. With 5.5% and 4.9% of the shares outstanding respectively, Moshe Mizrahy and Michael Kreindel are the second and third largest shareholders. Interestingly, the bottom two of the top three shareholders also hold the title of Chief Executive Officer and Member of the Board of Directors, respectively, suggesting that these insiders have a personal stake in the company. A closer look at our ownership figures suggests that the top 14 shareholders have a combined ownership of 50% implying that no single shareholder has a majority. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions. Our information suggests that insiders maintain a significant holding in InMode Ltd.. Insiders own US$129m worth of shares in the US$843m company. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling. The general public-- including retail investors -- own 13% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with InMode , and understanding them should be part of your investment process. If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

MGM Resorts International (MGM): A Bull Case Theory
MGM Resorts International (MGM): A Bull Case Theory

Yahoo

time24 minutes ago

  • Yahoo

MGM Resorts International (MGM): A Bull Case Theory

We came across a bullish thesis on MGM Resorts International (MGM) on MileHighMonk's Substack. In this article, we will summarize the bulls' thesis on MGM. MGM Resorts International (MGM)'s share was trading at $33.39 as of 10th June. MGM's trailing and forward P/E were 14.5 and 14.88 respectively according to Yahoo Finance. A bright and luxurious casino resort illuminated in the evening skyline. MGM Resorts International presents a diversified investment case rooted in dominant assets, global expansion, and disciplined capital returns. At its core is Las Vegas, where MGM commands a 40% market share with iconic properties like Bellagio and MGM Grand. Over half of Las Vegas' revenue is non-gaming, driven by hospitality, conventions, and entertainment, with partnerships like Marriott fueling room demand. MGM's regional casinos add stability, generating over $1.1 billion in annual EBITDAR with low capital intensity. In Macau, MGM has doubled its market share to 16% since 2018, riding mass-market recovery and expanding premium offerings, supported by a $2 billion loan for growth and refinancing. Japan represents a future growth engine, with MGM's $10 billion Osaka resort projected to generate $3.6 billion in annual revenue. Meanwhile, BetMGM, a 50/50 venture with Entain, has captured a leading position in U.S. iGaming and online sports betting, producing $424 million in 2024 EBITDA. With a potential EBITDA of $500 million and a conservative 10x multiple, MGM's stake could be worth $2.5 billion. Despite these high-quality assets, MGM trades at a discount to peers across both P/E and EV/EBITDA metrics, further distorted by its lease-heavy, asset-light model that inflates leverage optics. Still, net debt excluding leases is only ~$4 billion. The company has repurchased nearly $9 billion of stock since 2021, cutting share count by 45%, and continues aggressively buying back shares under a new $2 billion program. Backed by IAC's 23% stake and long-term conviction, MGM is viewed as a 'forever asset' with near- and long-term catalysts underappreciated by the market. Previously, we covered a bullish thesis on MGM Resorts (MGM) by David on Substack, which emphasized the company's asset-light transformation, iconic Las Vegas assets, and aggressive buybacks driving per-share value. The stock price has appreciated by roughly 27% since the coverage in April 2025. MileHighMonk expands on this view, highlighting MGM's global growth via Macau and Japan, BetMGM's digital upside, and valuation gaps versus peers despite strong capital returns. MGM Resorts International (MGM) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 52 hedge fund portfolios held MGM at the end of the first quarter which was 47 in the previous quarter. While we acknowledge the risk and potential of MGM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store